Search Ontology:
ChEBI

rivaroxaban

Term ID
CHEBI:68579
Synonyms
  • 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide
  • BAY 59-7939
  • BAY59-7939
  • rivaroxaban
  • Xarelto
Definition
A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-chlorothiophene-2-carboxylic acid with the amino group of 4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one. An anticoagulant used for prophylaxis of venous thromboembolism in patients with knee or hip replacement surgery.
References
  • cas:366789-02-8
  • drugbank:DB06228
  • drugcentral:4182
  • kegg.drug:D07086
  • lincs.smallmolecule:LSM-5499
  • patent:EP1685841
  • patent:US2005182055
  • patent:US2007026065
  • patent:US2009036504
  • patent:US2010151011
  • patent:US2011034453
  • patent:US2011112083
  • patent:US2011152266
  • patent:US2011288294
  • patent:US7816355
  • patent:WO2004060887
  • patent:WO2005068456
  • patent:WO2008140220
  • patent:WO2011080341
  • patent:WO2012035057
  • patent:WO2012051692
  • pdb-ccd:RIV
  • pmc:PMC7292653
  • pubmed:22042412
  • pubmed:22173426
  • pubmed:22187012
  • pubmed:22242932
  • pubmed:22272729
  • pubmed:22372178
  • pubmed:22387577
  • pubmed:22422332
  • pubmed:22533680
  • pubmed:22534269
  • pubmed:22534775
  • pubmed:22542983
  • pubmed:22651881
  • pubmed:22664783
  • pubmed:22701330
  • pubmed:22740145
  • pubmed:22777255
  • pubmed:22800431
  • pubmed:22811404
  • pubmed:22871192
  • pubmed:22884545
  • pubmed:22932305
  • pubmed:22958812
  • pubmed:23006523
  • pubmed:23014816
  • pubmed:30653475
  • pubmed:31784708
  • pubmed:32002769
  • pubmed:32023227
  • pubmed:32223113
  • pubmed:32223511
  • pubmed:32252075
  • pubmed:32265542
  • pubmed:32279215
  • pubmed:32296145
  • pubmed:32382756
  • pubmed:32519800
  • pubmed:32548552
  • pubmed:32548556
  • reaxys:10206739
  • wikipedia.en:Rivaroxaban
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from rivaroxaban
Phenotype where environments contain rivaroxaban
Phenotype modified by environments containing rivaroxaban
Phenotype affecting rivaroxaban
Human Disease Model